Isocare 1000 mg/g Inhalation Vapour, Liquid

Țară: Irlanda

Limbă: engleză

Sursă: HPRA (Health Products Regulatory Authority)

Ingredient activ:

Isoflurane

Disponibil de la:

Animalcare Limited

Codul ATC:

QN01AB06

INN (nume internaţional):

Isoflurane

Dozare:

1000 milligram(s)/gram

Forma farmaceutică:

Inhalation vapour, liquid

Tip de prescriptie medicala:

VPO: Veterinary Practitioner Only as defined in relevant national legislation

Grupul Terapeutică:

Cats, Dogs, Ferrets, Gerbils, Guinea pigs, Hamsters, Horses, Other Birds, Reptiles

Zonă Terapeutică:

isoflurane

Indicații terapeutice:

Neurological Preparations

Statutul autorizaţiei:

Authorised

Data de autorizare:

2016-08-16

Caracteristicilor produsului

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Isocare 1000 mg/g Inhalation Vapour, Liquid
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
Isoflurane 1000 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Inhalation Vapour, Liquid
Clear, colourless, volatile, liquid
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters,
chinchillas, gerbils, guinea pigs and ferrets.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction and maintenance of general anaesthesia.
4.3 CONTRAINDICATIONS
Do not use in cases of known susceptibility to malignant hyperthermia.
Do not use in cases of known hypersensitivity to the active substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The metabolism of birds, and to an extent small mammals, is affected
more profoundly by decreases in body
temperature, due to high surface area to body weight ratio. Drug
metabolism in reptiles is slow and highly dependent
upon environmental temperature.
The ease and rapidity of alteration of the depth of anaesthesia with
isoflurane and its low metabolism may be
considered advantageous for its use in special groups of patients such
as old or young, and those with impaired hepatic,
renal or cardiac function.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_5_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_6_
_6_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_